On-Line Autotransfusion Waste Calculator
|
|
- Daniella Allison
- 8 years ago
- Views:
Transcription
1 The Journal of The American Society of Extra-Corporeal Technology On-Line Autotransfusion Waste Calculator Jeffrey B. Riley, MHPE, CCT;* Keith A. Samolyk, BS, CCP, LCP *Circulation Technology Division, School of Allied Medical Professions, The Ohio State University, Columbus, Ohio; and Global Blood Resources LLC, Somers, Connecticut Presented as a poster at the 45th International Conference of the American Society of Extra-Corporeal Technology, Atlanta, Georgia, April 26, Abstract: Cell concentrating and washing techniques are widely accepted and believed to be beneficial to cardiac surgery patients. During cell processing, platelets, proteins, and clotting factors are wasted as the plasma is washed away by saline. Beneficial and costly plasma constituents are sacrificed for the sake of removing potentially harmful drugs, debris, and naturally activated cells and chemical mediators. An interactive Microsoft Excel spreadsheet was designed to input patient and autotransfusion system (ATS) reservoir blood values, processed centrifugal bowl data, and hospital allogeneic blood product concentration and cost information. The spreadsheet calculates the number of wasted platelets, grams of protein, and milligrams of fibrinogen. The calculator further estimates the number of units and cost of allogeneic blood products needed to replace the wasted blood components. The simulation allows for variable levels of platelet activation and protein removal during centrifugal cell processing. Specific case scenarios may be simulated with the calculator. If a known volume of residual extracorporeal circuit blood with a known hematocrit, platelet count, and protein concentration is diverted to the ATS reservoir to be processed and washed after bypass, the number of units of fresh frozen plasma, platelet packs, and albumin concentrate needed to replace the wasted proteins and platelets may be calculated. When typical end-bypass patient and blood bank product values are input, the cost to replace the wasted blood components in 1550 ml of residual circuit blood with allogeneic blood products is about US $2097. There are risks and costs associated with replacing the platelets, proteins, and clotting factors wasted during cell washing compared with other techniques such as whole blood ultrafiltration. Keywords: cell processor, autotransfusion, cell washing, hemofiltration, ultrafiltration, Internet, ethics, blood salvaging, blood management. JECT 2007;40:68 73 Collection of whole shed autologous blood, concentrating and washing the red cells, and re-infusing the cells to the patient is an effective means of extracorporeal hemoconcentration and preservation of the patient s red cell mass during high blood loss surgical procedures (1). It is well established that whole blood centrifugation and cell washing wastes the buffy coat (BC), the plasma, and their cellular and proteineous constituents (2). The wasted cellular and plasma blood components are sacrificed during cell washing because clinicians believe that potentially undesired plasma vasoactive and immunologically reactive substances need to be washed from the red blood cells that normally would have been discarded with shed suction blood (3). Studies have analyzed the contents of collected shed blood and have studied the physiologic benefits of the reinfusion of filtered surgical shed blood (4). Address correspondence to: Jeffrey B. Riley, MHPE, CCT, Cardiovascular Perfusion Department, Mayo Clinic MB1 735, Saint Mary s Hospital, 1216 Second Street, SW, Rochester, MN riley.jeffrey@mayo.edu J.B. Riley is a consultant for Global Blood Resource LLC. Keith A. Samolyk is President and CEO of Global Blood Resources. Our purpose for creating the computer spreadsheet was to simulate the potential for retrieval of blood cells and proteins during the collection and washing of surgically shed autologous whole blood. Although the autologous red blood cell (RBC) volume saved may reduce the need, risks, and cost of allogeneic blood (5), the replacement of wasted BC, plasma cells, and proteins during large volume cell washing is costly (6). The spreadsheet model (SM) allows clinicians to simulate the effect of changing several variables associated with autotransfusion and cell washing, inserting values from their own local or regional experiences. The SM predicts the amount and replacement cost of valuable wasted plasma and BC constituents. This article focuses on the specific clinical strategy of washing residual cardiopulmonary bypass (CPB) extracorporeal circuit contents vs. ultrafiltrating the circuit blood to preserve BC and plasma components (7). MATERIALS AND METHODS Well-known variables and mathematical expressions to estimate cell volumes and protein weights in shed autolo- 68
2 ON-LINE AUTOTRANSFUSION WASTE CALCULATOR 69 gous or residual extracorporeal circuit (ECC) blood were entered into a Microsoft Office Excel 2003 spreadsheet (Microsoft Corp., Redmond, WA). The Excel spreadsheet was converted to an interactive web page using SpreadsheetConverter (Framtidsforum I&M AB, Uppsala, Sweden). The cells on the spreadsheet are color-coded so the user knows which cells are for user entry and which cells are calculated. When the user hovers the mouse cursor over the cell number, the definition and equation for the cell value appear in a comment box. After the user enters their simulation values, the user presses the update button and the SM calculates the estimated cell values based on the user s input. The results of the simulation may be printed or reset. A second Internet page (Table 1) is available that reports cell definitions and the equations used in each estimated spreadsheet cell. The SM first allows the user to characterize the contents of the autotransfusion system (ATS) reservoir by entering the shed blood hematocrit, platelet count, and protein concentrations. The user enters the wound irrigant volume and anticoagulant solution volume, if any. The spreadsheet calculates the volume of autologous blood in the reservoir. The SM estimates the RBC mass (RBCM) and the plasma mass in cubic centimeters. The user enters the ATS bowl volume and the expected percent bowl hematocrit. The SM returns the predicted number of processed bowls and the volume of the washed RBCs expected in the anesthesia reinfusion bag based on the RBCM in the ATS reservoir and the bowl characteristics. The SM predicts the millions (M) of wasted platelets, total milligrams (mg) of fibrinogen, and total grams (g) of protein wasted during cell washing after the user enters their estimated percent platelet activation or loss and the percent efficiency of protein removal by their ATS. The user enters information about their blood bank s volume, platelet, and fibrinogen concentrations and costs Table 1. Spreadsheet cell definitions and model equations. 1 The average patient (pt) hematocrit (hct) during shed blood collection 2 The average patient platelet count (plt cnt) during shed blood collection 3 The average patient total protein (port) concentration (conc) during shed blood collection 4 The average patient fibrinogen (fib) concentration during shed blood collection 5 Total volume in the reservoir before processing red cell mass (RBCM) 6 Surgical field irrigant volume (vol) 7 Heparinized saline volume 8 Total patient shed blood volume in reservoir [ reservoir irrigant hep saline vol] 9 RBCM in shed blood reservoir to be processed in bowl [ (hct/100) * reservoir vol] 10 Patient plasma volume in the reservoir [ patient shed vol RBCM] 11 ATS device bowl volume 12 Expected ATS bowl end-processing hct 13 Number of bowls to be filled to process reservoir RBCM [ reservoir RBCM/(bowl vol * (bowl hct/100))] 14 Total bowl volume transferred to anesthesiologist patient transfusion bag [ # of bowls * bowl vol] 15 The percent of platelets that are activated by the ATS process if not wasted 16 If there are 1,000 mm3 in one cc of plasma, the total number of platelets wasted [ (pt shed vol * 1000 mm3/cc * plt cnt)/10^6) * (100 % plt activation)] 17 The percent of the proteins that are removed by the ATS process 18 The total number of mg of fibrinogen that are discarded [ pt shed vol/100 dl/l * fib conc * (% prot removal)] 19 The total number of gm of protein that are discarded other than the fibrinogen mg [ (pt shed vol/100 dl/l * prot conc * % prot removal) (fib mg/1000)] 20 The volume in a platelet pack to determine the cost of platelets 21 The concentration of platelets in the platelet pack 22 The total number of platelets in the platelet pack example [ (plt pack vol * 100 mm3/cc * plt conc)/106] 23 The cost of the volume of platelets in the platelet pack 24 The volume in a unit of allogeneic fresh frozen plasma (FFP) 25 The concentration of fibrinogen in the FFP unit 26 Total number of mg of fibrinogen in the FFP unit example [ (FFP vol/100) * fib conc] 27 The cost of the FFP unit 28 The volume of the protein concentrate 29 The concentration by volume of the protein concentrate 30 Total number of gm of protein in the protein concentrate [ (prot conc/100) * prot vol] 31 Cost of the protein concentrate example 32 Number of platelet packs required to replace wasted platelets [ M wasted platelets/m of platelets in plt pack] 33 Cost to replace the total number of platelets expected to survive that were wasted during ATS [ # plt pack replacement * cost of plt pack] 34 Number of FFP units required to replace wasted fibrinogen [ mg wasted fibrinogen/mg in one FFP unit] 35 Cost to replace the total number of mg fibrinogen that are wasted during ATS [ # FFP unit replacement * cost of one FFP unit] 36 Number of protein vials required to replace wasted protein [ gm wasted protein/gm in one protein vial] 37 Cost to replace the total number of gm protein (minus fibrinogen) that are wasted during ATS [ # prot vials replacement * cost of one protein vial] 38 Total cost to replace fibrinogen, protein and platelets lost during ATS processing [ sum of plt pack cost + FFP unit cost + prot conc cost] 39 Cost of the Hemobag and hemoconcentrator 40 Total cost of recovered waste minus cost of Hemobag and hemoconcentrator [ cost of waste cost of Hemobag and HC]
3 70 J.B. RILEY AND K.A. SAMOLYK for allogeneic platelet packs and fresh frozen plasma (FFP). If the user does not have information regarding their blood bank products, values from the literature are available such as found in Table 2 (8). The SM requires input for the volume, concentration, and cost of the user s routinely used protein substitute. The SM next estimates the total number and cost of platelet packs, FFP packs, and protein vials needed to replace the wasted BC and plasma components estimated by the user for a specific clinical scenario. The total cost is calculated. Although not included in the SM, Equation 1 may be used to calculate the cost savings for avoiding the use of allogeneic packed red blood cells while cell centrifugation and washing or by concentration with ultrafiltration. RBCM US$ = ATS Vol PRBC * Hct PRBC 100 * US$ PRBC Eq. 1 where RBCM ATS 100% Hct red blood cell mass (ml) saved by ATS; Vol PRBC average volume (ml) in one unit of PRBCs; Hct PRBC average Hct for unit of PRBCs; and US$ PRBC average cost of one unit of PRBCs. The SM was further designed to allow clinicians to enter the cost of the alternative therapy to washing residual ECC blood, the Hemobag technique (Global Blood Resources, Somers, CT), and to calculate the potential savings if the BC and plasma components are not washed away. RESULTS Table 3 presents a completed spreadsheet model for an ATS procedure where 2200 ml of 28% hematocrit autologous shed blood is mixed with 400 ml of heparin solution and 250 ml of wound irrigant. Realistic shed blood platelet count (150/mm 3 ), fibrinogen (125 g/dl), and protein concentrations (4.5 g/dl) are entered (9). A 225-mL bowl and a wash process that yields a hematocrit of 55% with 90% protein removal and 10% platelet retention are Table 2. Allogeneic blood component composition and cost. Component $ Cost Vomume (ml) Concentration Note Platelet /L Platelet count pack FFP mg/dl Fibrinogen concentration Albumin % Albumin concentration prbcs % Percent hematocrit $ Cost, cost to hospital; prbcs costs, non-irradiated and not leukodepleted; all other values reported are mean values from quality monitoring. simulated. Values for the SM allogeneic blood product volumes, concentrations, and costs come from the Transfusion Medicine Department at The Ohio State University (M. Kennedy, personal communication, April, 2007; Table 2). The SM predicts that the replacement cost of the wasted BC and plasma cells and proteins would be US $3089 if the shed blood is ultrafiltrated rather than cell washed. Table 4 presents a completed spreadsheet model for not cell washing 1550 ml of residual CPB circuit blood transferred from the ECC to the ATS reservoir. The residual circuit blood values were derived from prior reports (7). The values for the bowl dynamics and the ATS preservation of proteins and platelets are similar to the values used in Table 2. The same allogeneic blood product volumes, costs, and concentrations used in Table 2 are repeated in Table 4. The SM predicts the cost to replace the residual circuit BC and plasma constituents is US $2097. Subtracting US $236 for a Hemobag and hemoconcentrator predicts a savings of US $1861 if the ECC blood is ultrafiltrated and not washed. More than 800 international individuals have visited the ATS waste calculator website since it was activated in November DISCUSSION The on-line Excel spreadsheet model described here allows clinicians to evaluate the cost of their ATS waste using assumptions specific to their equipment and their institutional blood bank products and costs. According to the SM, the cost to replace the BC and plasma cellular and protein components is substantial and often is evaluated to thousands of dollars for routine ATS and post-cpb cell washing scenarios (Table 2). The SM dramatically shows (Table 4) that the use of the Hemobag technique to concentrate the residual CPB circuit blood will conserve the equivalent of thousands of dollars worth of allogeneic blood products for each individual patient where it is used. Table 3 presents a simulated routine ATS procedure and raises an interesting point. The cost of the replacement blood products in the ATS procedure represents the possible savings if the shed blood and plasma were hemoconcentrated instead of centrifuged and washed. The reinfusion of unwashed shed blood is controversial, and many studies have shown that there is no significant measurable physiologic response to the immunologically active substances found in shed blood (10). There are clinical situations where the ATS reservoir shed blood volume may be ultrafiltered and safely reinfused as opposed to centrifuged and washed. The ATS waste calculator evaluates the financial motivation for reinfusion of shed autologous whole blood. The SM has limitations in that clinicians are required to
4 ON-LINE AUTOTRANSFUSION WASTE CALCULATOR 71 Table 3. ATS waste cost estimator for typical ATS surgical procedure. enter values for parameters that they may not know. The morbidity and costs of treating diseases associated with transfusions, which can be very high, are not included in the SM. Clinicians may not know the shed blood hematocrit, platelet, fibrinogen, and protein concentrations. The clinician must also estimate the bowl hematocrit, which they may or may not have measured. The other parameters that are difficult to estimate are the platelet loss or retention and the protein removal in the ATS washing process, unless the clinicians have measured the values. To predict the number of replacement allogeneic blood product packs, assumptions are made about donor pack volumes and concentrations that are variable. Despite these limitations, it is easy to simulate the final cost consequences of small changes in any one parameter in the SM if there is concern regarding the accuracy of one scenario estimate. The cost of replacing wasted shed plasma during cell washing is even greater when the loss of factors VII, VIII, IX, X, and XIII are considered in the replacement model,
5 72 J.B. RILEY AND K.A. SAMOLYK Table 4. ATS waste cost estimator for residual CPB circuit blood. because economically, there are stand alone companies offering these recombinant factors to the hospital setting at exorbitant pricing. The off-label strategic supplemental use of specific clotting factors (e.g., FVII) during hemorrhage is being widely reported (11). Table 4 shows the theoretical and potential cost savings associated with concentrating the residual ECC blood using the Hemobag technique in place of wasting the ECC plasma. It makes sense to preserve the plasma from residual circuit blood or from surgical shed blood (12) whenever possible to avoid the possible use of costly factor therapy. Clotting factor VII, IX, and X levels in the concentrated residual ECC blood have been reported as high as 259% of baseline (13) using the Hemobag. In addition, the patient infusion of allogeneic blood products is tantamount to an organ transplant with the typical recipient responses to foreign tissue and the associated diseases and costs (6). Current validation of the ATS waste calculator is based on a review of the evidence-based literature applied to the
6 ON-LINE AUTOTRANSFUSION WASTE CALCULATOR 73 ATS cell washing model and on several observation studies of outcomes related to the ultrafiltration techniques. Future validation of the ATS waste calculator model will be based on the analysis of shed and allogeneic blood component content and their related costs. Autologous whole blood is at the very crux of individual survival, and it has quickly become the most precious and personal substance on the planet. The issues of blood component conservation through conscientious blood management and allogeneic transfusion avoidance are not just based on financial reasoning, but are much more complex and have both moral and ethical consequences, as well as the looming oversight that is on the horizon that will encompass all the individuals that are directly involved with this most precious of substances (14). ACKNOWLEDGMENTS The authors acknowledge and appreciate the technical assistance of Pat Letendre, MEd, University of Alberta, Edmonton, Alberta, Canada, for converting and posting the on-line ATS waste calculator, and Scott Beckmann, BS, CCP, Salem Hospital, Salem, OR, for insight and sharing his clinical experience. REFERENCES 1. Dickinson T, Riley J, Steg A, Zabetakis P. Observations from a national multiple institution autotransfusion (ATS) quality indicator program. J Extra Corpor Technol. 2004;36: Stammers AH, Morrow JF, Brady CP, et al. Ultrafiltration of the waste plasma effluent from cardiopulmonary bypass circuit contents processed with a cell-washing device. J Extra Corpor Technol. 1996; 28: Webb DP, Altenbern CP, Tritt C, Downey FX, Minkel D. Pulmonary implications of filtering various mediators of morbidity found in salvaged blood. J Extra Corpor Technol. 1998;30: Munoz M, Ariza D, Garceran MJ, Gomez A, Campos A. Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement. Arch Orthop Trauma Surg. 2005;125: Van der Linden P, Dierick A. Blood conservation strategies in cardiac surgery. Vox Sang. 2007;92: Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004;8: Beckmann S, Carlile D, Bissinger R, Burrell M, Winkler T, Shely W. Case series: Hematological changes in the golden hours after CPB with an off-line technique of modified ultrafiltration of residual circuit blood utilizing the Hemobag. J Extra Corpor Technol. 2006;38: Whitaker BI, Sullivan M. The 2005 Nationwide Blood Collection and Utilization Survey Report. Bethesda, MD: American Association of Blood Banks; Serrick C, Scholz M, Melo A, Singh O, Noel D. Quality of red blood cells using autotransfusion devices: A comparative analysis. J Extra Corpor Technol. 2003;35: Helwig U, Schaub S, Berghold A, Ziervogel H. Coagulation parameters after retransfusion of unwashed blood. J Arthroplasty. 2006;21: Bishop CV, Renwick WE, Hogan C, Haeusler M, Tuckfield A, Tatoulis J. Recombinant activated factor VII: Treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg. 2006;81: Dekkers RJ, Rizzo RJ, Fitzgerald DJ, Cohn LH. A modified collection and rapid infusion system for shed whole blood autotransfusion during aortic aneurysm surgery. J Extra Corpor Technol. 1995;27: Samolyk KA, Beckmann SR, Bissinger RC. A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag. Perfusion. 2005;20: Sazama K. The ethics of blood management. Vox Sang. 2007;92:
Navigating the Regulatory Issues of Blood Management
Navigating the Regulatory Issues of Blood Management Bob Dyga RN, CCP, LP, CPBMT Vice President, Perfusion Operations UPMC/Procirca History of Transfusion Medicine Blundell s Blood Gravitator h2p://bloodjournal.hematologylibrary.org/content/112/7/2617/f5.large.jpg
More informationYvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI
Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Overview of Hematology, http://www.nu.edu.sa/userfiles/mhmorsy/h
More informationTransfusion Medicine
Transfusion Medicine Chapter 5 Transfusion Medicine Routine Transfusion Therapy Blood products should not be transfused on a unit basis in children Base the volume of transfusion products on weight to
More informationSARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES
SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES TABLE OF CONTENTS SUBJECT PAGE ADULT CRITERIA Red Blood Cells/Autologous 2 Washed Red Blood Cells 2 Cryoprecipitate
More informationSTANDARD BLOOD PRODUCTS AND SERVICES
STANDARD BLOOD PRODUCTS AND SERVICES Policy NHP reimburses contracted providers for the medically necessary administration (transfusion) of blood and standard blood products. Prerequisites Authorization,
More informationBusiness Concept: Anemia Center/Clinic/Service Proposal submitted by Department of Blood Management
Business Concept: Anemia Center/Clinic/Service Proposal submitted by Department of Blood Management Concept Name Anemia Center/Clinic/Service, Pre-op Treatment Center, Blood Management Outpatient Service,
More information1. BLOOD GROUP SYSTEMS. Page 1. Haematology LECTURE 10. BLOOD GROUPS AND TRANSFUSIONS OVERVIEW. 1. Blood Group Systems
Undergraduate Course in Veterinary Clinical PathologySocrates Programme Haematology LECTURE 10. BLOOD GROUPS AND TRANSFUSIONS 10-1 OVERVIEW 1. Blood Group Systems 2. Blood group testing and cross-matching
More informationTranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies
Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and
More informationBlood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
More information14.0 Stem Cell Laboratory Services
Laboratory Services Contact Information: To inquire about assisting with surgical harvesting of bone marrow, cellular therapy (CT) product processing, cryopreservation, storage, or any other lab services,
More informationBlood Sticky, opaque fluid with a metallic taste (Fe 2+ ) Varies from scarlet (P O2 = 100) to dark red (P O2 = 40) ph is between 7.35 and 7.45 Average volume in an adult is 5 L (7% of body weight) 2 L
More informationThe 2011 National Blood Collection and Utilization Survey Report
The 2011 National Blood Collection and Utilization Survey Report The United States Department of Health and Human Services 2011 National Blood Collection and Utilization Survey was conducted under contract
More informationGuideline Statement for the Treatment of Disseminated Intravascular Coagulation
Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Introduction Though a rare occurrence in the perioperative setting, disseminated intravascular coagulation (DIC) is a syndrome
More informationINDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS
INDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS Sarah Perry, LVT, BS, VTS (ECC) Licensed Veterinary Technician Animal Neurology, Rehabilitation and Emergency Center 1120 Welch Rd. Commerce, MI 48390 A very
More informationBlood products and pharmaceutical emergencies
Blood products and pharmaceutical emergencies Kasey L. Bucher PharmD, BCPS Clinical Specialist, Emergency Medicine Mercy Health Saint Mary s September 12, 2013 Disclosures None significancemagazine.com
More informationIntroduction to Blood Management
Introduction to Blood Management What is Blood Management? Preventing a blood transfusion to the patient who doesn t need one Right blood product, at the right time, in the right dose, to the right patient
More informationWelcome to esessions Operational Principles of Therapeutic Plasma Exchange (TPE) Procedures
Welcome to esessions Operational Principles of Therapeutic Plasma Exchange (TPE) Procedures COBE Spectra Apheresis System Presented by CaridianBCT TPE Disposable Tubing Set ACD-A Plasma Plasma Waste Bag
More informationBLOOD COLLECTION. How much blood is donated each year and how much is used?
BLOOD COLLECTION How much blood is donated each year and how much is used? Each unit of blood consists of a volume of 450-500 milliliters or about one pint. Because of the constant demand for blood, about
More informationSuggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction
Suggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction March 27, 2014 Steve Kleinman, MD TRALI: A brief history Identified as a non-infectious serious hazard of transfusion in the
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationPreparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between
Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program ISCT 2012 Disclosures: none The problem:
More informationa personal guide to Chest Drainage
a personal guide to M A N A G I N G Chest Drainage AUTOTRANSFUSION Table Of Contents Your personal guide to Managing Chest Drainage Autotransfusion is a quick and easy reference to help extend your understanding
More informationGUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY
BLOOD CONSERVATION STRATEGIES IN CARDIAC SURGERY: MORE IS BETTER GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY DIMITRIOS V. AVGERINOS MD, PhD, FACS, FACC Department of Cardiac Surgery,
More informationStem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationRed blood cell transfusions in the Netherlands Towards (very) low use
Red blood cell transfusions in the Netherlands Towards (very) low use Marian G.J. van Kraaij, MD PhD hematologist/ transfusion medicine specialist Director Dept Transfusion Medicine Sanquin Blood Supply,
More informationFresh Frozen Plasma INTRODUCTION COAGULOPATHY AND DAMAGE CONTROL SURGERY WHAT IS FRESH FROZEN PLASMA?
Fresh Frozen Plasma LTC Clayton D. Simon, MC, USA MAJ(P) Jeremy Perkins, MC, USA LTC Paul Barras, AN, USA COL Brian Eastridge, MC, USA COL Lorne H. Blackbourne, MC, USA INTRODUCTION For years, much has
More informationBLOOD BANK ANNUAL STATISTICS (HOSPITALS)
New Jersey Department of Health Clinical Laboratory Improvement Services PO Box 361 Trenton, NJ 08625-0361 BLOOD BANK ANNUAL STATISTICS (HOSPITALS) County Code Number Address Name of Individual Completing
More informationTo assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).
MANAGEMENT OF BLEEDING IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To assist clinicians
More informationDirected, Autologous and Therapeutic Donations
Directed, Autologous and Therapeutic Donations Directed Donations: What is a directed donation? A directed donation is when a specific donor makes a blood donation at the request of a patient and the patient
More informationBLOOD GROUP ANTIGENS AND ANTIBODIES
BLOOD GROUP ANTIGENS AND ANTIBODIES Over 20 blood group systems having approximately 400 blood group antigens are currently recognised. The ABO and Rhesus (Rh) blood group systems are of major clinical
More informationStop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery
Stop the Bleeding: Management of Drug-induced Coagulopathy Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Objectives Discuss contemporary management of warfarin reversal in patients
More informationTHE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE
FACTS AND FIGURES JUNE 2004 NO 2 THE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE Revised Edition Shân Lloyd National Blood Transfusion Service Zimbabwe Published by the World Federation of Hemophilia (WFH);
More informationPeripheral Blood Stem Cell (PBSC) Collections: Why, What, When. Objectives. Sources of Stem Cells
Peripheral Blood Stem Cell (PBSC) Collections: Why, What, When Objectives Why do need stem cell transplants What type of cells are we using for stem cell transplants When and how we collect peripheral
More informationNew Oral Anticoagulants
Laboratory Monitoring of New Oral Anticoagulants.....What you need to know Rita Selby MD Medical Director, Coagulation Laboratories Uniersity Health Network & Sunnybrook HSC Uniersity of Toronto The 15
More informationFRANCES P. VELA-CANTOS, APN-c
FRANCES P. VELA-CANTOS, APN-c EXPERIENCE 6/00 - present Acute Care Nurse Practitioner Clinical Research Coordinator Heart and Vascular Institute of New Jersey Division of Cardiothoracic Surgery Englewood
More informationDate effective: Jan 2005 Date revised: June 2015
Section H: Administration of Blood Products Page 1 of 8 I. Introduction... 1 II. Intravenous (IV) Access... 2 Peripheral Line:...2 Central Venous Catheter:...2 III. Compatible Solutions with Blood Products...
More informationELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS
ELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS PURPOSE The "" is a document developed by the Extracorporeal Life Support Organization (ELSO) as a reference for current and future
More informationKEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.
KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term
More informationLABORATORY PROCEDURE MANUAL
Exercise 2 Donor Physical Exam Textbook: Skills: 20 points Objectives 1. For each of the following state the acceptable values for blood donation using appropriate units: a. Pulse b. Temperature (Celsius
More informationSTANDARD OPERATING PROCEDURE FOR RESOLVING ABO & Rh BLOOD GROUP DISCREPANCIES
STANDARD OPERATING PROCEDURE FOR RESOLVING ABO & Rh BLOOD GROUP DISCREPANCIES TITLE: STANDARD OPERATING PROCEDURE FOR RESOLVING ABO & RH BLOOD GROUP DISCREPANCIES 1.0 Principle 1.1 To resolve ABO and Rh
More informationInformation for patients needing irradiated blood
Information for patients needing irradiated blood Patient information I am at risk of transfusion-associated graft-versus-host disease If I need to have a blood transfusion, cellular blood components (Red
More informationBlood System Inventory Management Best Practices Guide
Blood System Inventory Management Best Practices Guide Blood is a precious resource that must be carefully managed to ensure that each donor s gift provides the greatest benefit to patients. Blood system
More informationPlasma Optimization Guide. Improving Plasma Yields from Whole Blood Donations
Plasma Optimization Guide Improving Plasma Yields from Whole Blood Donations Table of Contents Plasma Optimization Guide...3 Overview...3 Blood Separation and Centrifugation...4 Introduction...4 Principles
More informationDirect Antiglobulin Test (DAT)
Exercise 8 Exercise 9 Direct Antiglobulin Test (DAT) Elution Study Task Aim Introduction To perform the DAT and elution procedure with correct interpretation of results. To perform with 100% accuracy the
More informationDamage Control in Abdominal Trauma
Damage Control in Abdominal Trauma Steven Stylianos, MD Surgeon-in-Chief, Morgan Stanley Children s Hospital Rudolph Schullinger Professor of Surgery, Columbia University College of Physicians & Surgeons
More informationCord Blood: Thawing & Infusion Practical Methods
Cord Blood: Thawing & Infusion Practical Methods Donna M Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Objectives Present variety of product configurations
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationAktuelle Literatur aus der Notfallmedizin
05.02.2014 Aktuelle Literatur aus der Notfallmedizin prä- und innerklinisch Aktuelle Publikationen aus 2012 / 2013 PubMed hits zu emergency medicine 12,599 Abstract OBJECTIVES: Current American Heart
More informationCRRT: I and O. I and O Sheet
CRRT: I and O I and O Sheet The following slide outlines a 12 hour CRRT I and O record. The individual lines of the I and O portion of the record will be reviewed. At the end of each hour, the ICU nurse
More informationBLOOD BANK SPECIMEN COLLECTION PROCEDURE
BLOOD BANK SPECIMEN COLLECTION PROCEDURE INTRODUCTION Scientific and technical advances in blood group serology have made the transfusion of blood a relatively safe procedure, but serious adverse effects
More information37 2 Blood and the Lymphatic System Slide 1 of 34
1 of 34 Blood is a connective tissue that contains both dissolved substances and specialized cells. 2 of 34 The functions of blood include: collecting oxygen from the lungs, nutrients from the digestive
More informationJOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR. 2nd Edition
JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR CliniCAl laboratories 2nd Edition Effective 1 April 2010 International Patient Safety Goals (IPSG) Goals The following is a list of all goals.
More informationMEDICAID PURCHASING ADMINISTRATION (MPA) Blood Bank Services Billing Instructions
MEDICAID PURCHASING ADMINISTRATION (MPA) Blood Bank Services Billing Instructions About This Publication This publication supersedes all previous Department Blood Bank Services Billing Instructions published
More informationPHYSICIAN ASSISTANT STUDIES UTMB ESSENTIAL FUNCTIONS AND TECHNICAL STANDARDS Updated 04/10/13
PHYSICIAN ASSISTANT STUDIES UTMB ESSENTIAL FUNCTIONS AND TECHNICAL STANDARDS Updated 04/10/13 This description defines the capabilities that are necessary for an individual to successfully complete the
More informationReversal of Anticoagulants at UCDMC
Reversal of Anticoagulants at UCDMC Introduction: Bleeding complications are a common concern with the use of anticoagulant agents. In selected situations, reversing or neutralizing the effects of an anticoagulant
More informationAppendix G - Identification and Selection of Studies
FINAL Emergency framework for rationing of blood for massively bleeding patients during a red phase of a Appendix G - Identification and Selection of Studies Inclusion/Exclusion Criteria We included studies
More informationPractice Guidelines for Perioperative Blood Management
Practice Guidelines for Perioperative Blood Management An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management* P RACTICE guidelines are systematically
More informationBlood Transfusion. Red Blood Cells White Blood Cells Platelets
Blood Transfusion Introduction Blood transfusions are very common. Each year, almost 5 million Americans need a blood transfusion. Blood transfusions are given to replace blood lost during surgery or serious
More informationQUICK REFERENCE TO BLOOD BANK TESTING
QUICK REFERENCE TO BLOOD BANK TESTING All Blood bank Tests are performed on demand 24 hours a day, 7 days a week. Feto/Maternal Bleed Quantitation estimates will be available within 4 hours of blood bank
More informationBlood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.
Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.
More informationUSE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)
USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals:
More informationHow Do I Implement A Hospital- Based Blood Management Program
How Do I Implement A Hospital- Based Blood Management Program Richard R. Gammon, MD Medical Director FABB Annual Meeting June 6, 2014 Learning Objectives Discuss steps needed to implement a patient blood
More informationDabigatran (Pradaxa) Guidelines
Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without
More informationBlood Plasma Sample Collection and Handling for Proteomics Analysis - A guide to obtain optimal plasma samples -
Blood Plasma Sample Collection and Handling for Proteomics Analysis - A guide to obtain optimal plasma samples - 1 Introduction Blood can be regarded as a complex liquid tissue that comprises cells and
More informationHEMATOCRIT/HCT AND CALCULATED HEMOGLOBIN/HB
HEMATOCRIT/HCT AND CALCULATED HEMOGLOBIN/HB Hematocrit is determined conductometrically. The measured conductivity, after correction for electrolyte concentration, is inversely related to the hematocrit.
More informationPoint-of-care testing Thrombelastography and platelet transfusion
Point-of-care testing Thrombelastography and platelet transfusion Gisela Scharbert Department of Anesthesiology, Intensive Care and Pain Management Vienna Medical University, Austria Trauma-induced coagulopathy
More informationPERIPHERAL STEM CELL TRANSPLANT INTRODUCTION
PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure
More informationThe classic blood supply chain (Fig. 1) travels
Unlocking the essentials of effective blood inventory management Judith Chapman The classic blood supply chain (Fig. 1) travels from the donor through all aspects of processing, testing, and issue in the
More informationCPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD
The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes
More informationClinical Practice Guidelines for Blood Transfusions
Clinical Practice Guidelines for Blood Transfusions Purpose: To provide practice guidelines regarding the transfusion of blood and blood components and to advance the safety and quality of care for the
More information2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines*
: STS WORKFORCE ON EVIDENCE BASED SURGERY 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines* The Society
More informationUMBILICAL CORD BLOOD, STEM CELL BANKING
UMBILICAL CORD BLOOD, STEM CELL BANKING Dr.Sharad Jain MD Blood Transfusion officer, & I/C Transfusion Medicine NSCB Medical College. Jabalpur.MP. Introduction: Every parent during childbirth DREAMS the
More informationPlanning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation
Obtain complete heath history including allergies, drug history and possible drug Assess baseline coagulation studies and CBC Assess for history of bleeding disorders, GI bleeding, cerebral bleed, recent
More informationGuidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods Blood Products Advisory Committee, March 9, 2006 Steven Kleinman, MD Senior Medical Advisor, AABB Co-chair, AABB
More informationV: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217
V: Infusion Therapy Alberta Licensed Practical Nurses Competency Profile 217 Competency: V-1 Knowledge of Intravenous Therapy V-1-1 V-1-2 V-1-3 V-1-4 V-1-5 Demonstrate knowledge and ability to apply critical
More informationMCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013 Anticoagulants Anticoagulants are agents that prevent the formation of blood clots. Before we can talk about
More informationXabans Good for What Ails Ya? Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center
Xabans Good for What Ails Ya? Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center DISCLOSURES No relevant financial disclosures I will
More informationPRISMAFLEX CRRT SYSTEM
THE PRISMAFLEX CRRT SYSTEM Recover. patients benefit There s a simple reason why the Prismaflex system is used more than any other Continuous Renal Replacement Therapy (CRRT) It s a complete system with
More informationLAMC Reversal Agent Guideline for Anticoagulants 2013. Time to resolution of hemostasis (hrs) Therapeutic Options
LAMC Reversal Agent Guideline for Anticoagulants 2013 Medication resolution of hemostasis (hrs) Intervention Administration Instructions Heparin 3-4 Protamine 1mg IV for every 100 units of heparin Slow
More informationEmbedding Point of Care monitoring (ROTEM) in daily practice
Embedding Point of Care monitoring (ROTEM) in daily practice Yvonne Henskens Clinical chemist Head of unit General Hematology, Hemostasis and Transfusion Central Diagnostic Laboratory Road to ROTEM 2009
More informationNnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatment
More informationHeart Center Packages
Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com
More informationPublic Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden
HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services
More informationCORD BLOOD EVALUATION
CORD BLOOD EVALUATION Principle: When there is incompatibility between a mother s antibodies and an infant s red blood cell antigens, the infant is at risk of developing Hemolytic Disease of the Fetus
More informationMalpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! Why this talk? Why me?
Malpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! G.R. Donowitz 2015 Why this talk? Why me? Expert witness for a long time Defense and Plaintiff work Have said, No, no case and
More informationABO-Rh Blood Typing Using Neo/BLOOD
ABO-Rh Blood Typing Using Neo/BLOOD Objectives Determine the ABO and Rh blood type of unknown simulated blood samples. Prepare a simulated blood smear. Examine a prepared blood smear under the microscope
More informationFACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
More informationCollect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
More informationHuman Clinical Study for Free Testosterone & Muscle Mass Boosting
Human Clinical Study for Free Testosterone & Muscle Mass Boosting GE Nutrients, Inc. 920 E. Orangethorpe Avenue, Suite B Anaheim, California 92801, USA Phone: +1-714-870-8723 Fax: +1-732-875-0306 Contact
More informationCRRT with Prismaflex LEADS TO More Flexibility, Ease of Use and Safety
CRRT with Prismaflex LEADS TO More Flexibility, Ease of Use and Safety Leading the way Science is changing and so are your requirements For many years, Gambro has focused its efforts on development of
More informationA Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs
A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory
More informationDirected to Dr. Carrier from NBRHC audience Q: In patients with GI Bleed history, would you suggest Apixaban for newly diagnosed patients
9 th Annual CBS/ORBCoN Transfusion Medicine Videoconference Symposium: April 9, 2014 Question and Answer Period Morning Session: Directed to Dr. Carrier from Dr. Bormanis Q: If the half lives are similar
More informationCHAPTER 2: BLOOD CIRCULATION AND TRANSPORT
CHAPTER 2: BLOOD CIRCULATION AND TRANSPORT BLOOD CIRCULATION AND TRANSPORT HUMAN BEING PLANTS Function of heart Wilting Structure of heart Blood vessels: characteristics and functions Transpiration: function
More informationBlood Management. System
Blood Management System Caring for your health JMS designs up-to-date blood management products with our patients and donors in mind. About us JMS started manufacturing blood bags in 1969 and have now
More informationLABORATORY DIAGNOSIS OF BLEEDING DISORDERS
LABORATORY DIAGNOSIS OF BLEEDING DISORDERS Secondary Hemostasis CIRCULATORY SYSTEM Low volume, high pressure system Efficient for nutrient delivery to tissues Prone to leakage 2º 2 to endothelial surface
More informationRadiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material)
Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material) Table of Content Receiving a Radioactive Package Constancy Test Daily Survey Weekly Wipes Accuracy Test Linearity Geometric
More informationThe Hemodialysis Machine Case Study
The Hemodialysis Machine Case Study Atif Mashkoor Software Competence Center Hagenberg GmbH Hagenberg, Austria atif.mashkoor@scch.at 1 Introduction This documents presents a description of a case study
More informationPlumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department!
Plumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department! EMS Section Chief! Department of Emergency Medicine! University of Missouri-Kansas
More informationTreating the Eye with Autologous and Allogeneic Serum Administration. Clarke D. Newman, OD, FAAO
Treating the Eye with Autologous and Allogeneic Serum Administration cdnewman@ earthlink.net Abstract: This one-hour course will detail the use of blood serum in the treatment of anterior ocular surface
More information»medical programs and services. transfusion medicine fellowship program
»medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers
More information